# C & F Financial Corp: Form 10-Q for the period ended Sep 30, 2022

- Company: [C & F Financial Corp](/companies/cffi.md) (CIK 913341)
- Form: 10-Q
- Filed: 2022-11-08
- Accepted by EDGAR: Nov 8, 2022, 13:35 ET
- Period: 2022-09-30
- Accession: 0000913341-22-000060
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/913341/000091334122000060/cffi-20220930x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/913341/000091334122000060/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2022-07-01 to 2022-09-30 | $30.5m | us-gaap:Revenues |
| Revenue | 9 months, 2022-01-01 to 2022-09-30 | $86.0m | us-gaap:Revenues |
| Interest expense | 3 months, 2022-07-01 to 2022-09-30 | $1.9m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2022-01-01 to 2022-09-30 | $5.5m | us-gaap:InterestExpense |
| Income tax | 3 months, 2022-07-01 to 2022-09-30 | $1.7m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2022-01-01 to 2022-09-30 | $5.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2022-07-01 to 2022-09-30 | $6.5m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2022-01-01 to 2022-09-30 | $18.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2022-07-01 to 2022-09-30 | $1.85 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2022-01-01 to 2022-09-30 | $5.34 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2022-07-01 to 2022-09-30 | $1.85 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2022-01-01 to 2022-09-30 | $5.34 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2022-07-01 to 2022-09-30 | 3,511,326 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2022-01-01 to 2022-09-30 | 3,531,064 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2022-01-01 to 2022-09-30 | $69.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2022-01-01 to 2022-09-30 | $2.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2022-01-01 to 2022-09-30 | $4.3m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months, 2022-01-01 to 2022-09-30 | $3.5m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Total assets | at 2022-09-30 | $2.34bn | us-gaap:Assets |
| Total liabilities | at 2022-09-30 | $2.15bn | us-gaap:Liabilities |
| Short-term borrowings | at 2022-09-30 | $37.6m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2022-09-30 | $184.8m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/913341/000091334122000060/cffi-20220930x10q.htm

Filed Nov 8, 2022.
Source: SEC EDGAR, the filing index for accession 0000913341-22-000060. Last ingested by Listed: Nov 14, 2026, 12:55 ET. No prices; not investment advice.
